Independent in relation to the Company and its management: Yes
Independent in relation to major shareholders: Yes
Holdings in Alligator: 367,696 shares, 100,000 warrants in program TO 2022/2025 II, 240,000 warrants in program TO 2023/2026 II and 160,000 warrants in program TO 2024/2027 II.
Other current positions: Chairman of Atrogi AB, Elypta AB and Xspray Pharma AB. Board member of AnaMar AB, Flerie Invest AB and Mereo BioPharma Group plc
Independent in relation to the Company and its management: Yes
Independent in relation to major shareholders: Yes
Holdings in Alligator: 2,111,884 shares, 100,000 warrants in program TO 2022/2025 II, 240,000 warrants in program TO 2023/2026 II and 160,000 warrants in program TO 2024/2027 II.
Other current positions: Chairman of the Board in Hoodin AB and NH3 AB, board member of InorbitTX, Oblique Therapeutics AB, Encare AB and Lennart Ekerholms Stiftelse. Deputy board member in O Mgmt AB.
Independent in relation to the Company and its management: Yes
Independent in relation to major shareholders: No
Holdings in Alligator: 249,948,630 shares.
Other current positions: Chairman of AnaMar AB, Sweden, a company engaged in the research and development of drugs for fibrosis, Koncentra AB, Sweden, a contract manufacturing group, Nclear Inc., Atlanta GA, a company in the water treatment business, Oxymetal SAS, France a laser and plasma steel cutting business and Sight Sciences Inc., Menlo Park CA, an eye care company developing and selling devices for surgical treatment of glaucoma and dry eye. Board member of KS Large Bore Pistons GmBH.
Independent in relation to the Company and its management: Yes
Independent in relation to major shareholders: Yes
Holdings in Alligator: 240,000 warrants in program TO 2023/2026 II and 160,000 warrants in program TO 2024/2027 II.
Other current positions: CEO of QED Life Sciences Limited, a consultancy company advising and supporting the strategic direction of biotech companies and providing business mentoring to CEOs and senior leaders. Board member of Abliva AB (publ) where she is chair of the remuneration committee and a member of the audit committee. VP, Business Development at AnaMar AB. Certified COVID vaccinator for the UK National Health Service.
Independent in relation to the Company and its management: Yes
Independent in relation to major shareholders: Yes
Holdings in Alligator: 100,000 warrants in program TO 2022/2025 II, 240,000 warrants in program TO 2023/2026 II and 160,000 warrants in program TO 2024/2027 II.
Other current positions: Chairman of the board of Dicot AB (publ) and Coegin Pharma AB. Board member of Apoex AB, Bluefish Pharmaceuticals AB (publ) and Oxcia AB. Deputy board member of Brainstorm Aktiebolag.
Independent in relation to the Company and its management: No
Independent in relation to major shareholders: Yes
Holdings in Alligator: 27,625 shares, 100,000 warrants in program TO 2022/2025 I, 180,000 warrants in program TO 2023/2026 I, 120,000 warrants in program TO 2024/2027 I and 4,875 warrants in program TO 9.
We use cookies for administering, monitoring and optimizing the website, and for analytical purposes, in accordance with what is stated in our
cookie policy.
